SC-560
| SC-560
| |
|---|---|
| Chemical data | |
| Chemical formula | C17H14O3
|
| SMILES | CC1=C(C(=O)C2=C(C1=O)C=CC(=C2)C)C3=CC=CC=C3
|
SC-560 is a selective cyclooxygenase-1 (COX-1) inhibitor, which is a type of nonsteroidal anti-inflammatory drug (NSAID). It is primarily used in research settings to study the role of COX-1 in various physiological and pathological processes.
Mechanism of Action[edit]
SC-560 selectively inhibits the enzyme cyclooxygenase-1 (COX-1), which is responsible for the conversion of arachidonic acid to prostaglandins. Prostaglandins are lipid compounds that have diverse roles in inflammation, pain, and fever. By inhibiting COX-1, SC-560 reduces the production of prostaglandins, thereby exerting anti-inflammatory and analgesic effects.
Pharmacokinetics[edit]
The pharmacokinetic profile of SC-560 has been studied in various animal models. It is known to have a high affinity for COX-1, with minimal activity against cyclooxygenase-2 (COX-2). This selectivity is important for understanding the differential roles of COX-1 and COX-2 in inflammation and other physiological processes.
Clinical Applications[edit]
While SC-560 is not used clinically, it serves as a valuable tool in research to delineate the specific contributions of COX-1 in various diseases. Studies have utilized SC-560 to explore its effects in models of cardiovascular disease, cancer, and neurodegenerative disorders.
Research Studies[edit]
Research involving SC-560 has provided insights into the role of COX-1 in platelet aggregation, gastric mucosal protection, and renal function. For instance, studies have shown that COX-1 inhibition by SC-560 can reduce platelet aggregation, which is a critical factor in the prevention of thrombotic events.
Safety and Toxicity[edit]
As with other NSAIDs, the use of SC-560 in research must consider potential side effects, such as gastrointestinal irritation and renal impairment. However, its selective inhibition of COX-1 may offer a different safety profile compared to non-selective NSAIDs.
Also see[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
